Hormonal characteristics of patients with endometrial hyperplasia and carcinoma
Siiteri, P.K.
Acta Cytologica 24(6): 482-483
1980
ISSN/ISBN: 0001-5547 PMID: 6934673 Document Number: 155546
Document emailed within 1 workday
Related Documents
Greenwood, S.M. 1976: The relation of adenomyosis uteri to coexistent endometrial carcinoma and endometrial hyperplasia Obstetrics and Gynecology 48(1): 68-72Meissner, W.A.; Sommers, S.C.; Sherman, G. 1957: Endometrial hyperplasia, endometrial carcinoma, and endometriosis produced experimentally by estrogen Cancer 10(3): 500-509
Stachowicz, N.; Czekierdowski, A.; Daniłoś, Jław.; Smoleń, A.; Kotarski, J. 2005: Three-dimensional sonoangiography in diagnostic of endometrial hyperplasia and carcinoma. An assessment of vascularization indices and endometrial volume Przeglad Lekarski 62(9): 827-829
Borisov, I.; Maĭnkhard, K.; Tsankova, M. 1996: The relationship between simple and atypical endometrial hyperplasia and endometrial carcinoma Akusherstvo i Ginekologiia 35(4): 18-20
Sato, S. 1993: Evaluation of the degree of biological behavior in endometrial hyperplasia and endometrial carcinoma: an investigation of proliferative activity, oncogene, and extracellular matrix Nihon Sanka Fujinka Gakkai Zasshi 45(8): 776-788
Semiglazov, V.F.; Maximov, S.Y.; Bulgatova, Y., A.; Meshkova, I.Y.; Chepik, O.F.; Berstein, L.M. 2003: Risk of hyperplasia and endometrial carcinoma in breast cancer patients receiving adjuvant tamoxifen Voprosy Onkologii (Stsburg). 49(2): 198-204
Namiki, T. 1979: Pathology of endometrial hyperplasia and endometrial carcinoma Rinsho Byori. Japanese Journal of Clinical Pathology 27(11): 1020-1025
Prakansamut, N.; Sirayapiwat, P.; Triratanachat, S. 2014: The percentages of endometrial hyperplasia and endometrial cancer among polycystic ovary syndrome (PCOS) patients presenting with abnormal menstrual pattern Journal of the Medical Association of Thailand 97(2): 159-164
Gorchev, G. 1991: The clinical characteristics of atypical endometrial hyperplasia Akusherstvo i Ginekologiia 30(1): 24-28
Tabatabaie, A.; Karimi Zarchi, M.; Dehghani-Tafti, M.; Miratashi-Yazdi, A.; Teimoori, S.; Dehghani, A. 2013: Comparing letrozole with medroxyprogesterone acetate (MPA) as hormonal therapy for simple endometrial hyperplasia without atypia in adult and middle-aged women European Journal of Gynaecological Oncology 34(6): 552-555
Hausknecht, R.U.; Gusberg, S.B. 1969: Estrogen metabolism in patients at high risk for endometrial carcinoma. I. Urinary metabolites of H3-estradiol in normal postmenopausal women and those with endometrial carcinoma American Journal of Obstetrics and Gynecology 105(8): 1161-1167
Papadimitriou, G.; Razis, D.; Zis, J.; Dracopoulou, I. 1974: Preoperative hormonal treatment in endometrial carcinoma International Surgery 59(8): 397-399
Papadimitriou, G.; Razis, D.; Zis, J.; Dracopoulou, I. 1974: Preoperative hormonal treatment in endometrial carcinoma International Surgery 59(8): 397-399
Kopecný, J.; Rejthar, A. 1990: Possibilities of hormonal treatment of endometrial carcinoma Ceskoslovenska Gynekologie 55(6): 447-451
Verdeal, K.; Erturk, E.; Rose, D.P. 1986: Endometrial adenomatous hyperplasia and carcinoma and multiple endocrinopathies in rats exposed to N-nitrosomethylurea Anticancer Research 6(1): 5-10
Shenderëva, T.S.; Shvedova, L.A. 1981: Hormonal transformation characteristics of endometrial adenoacanthoma in the process of progestin treatment Voprosy Onkologii 27(10): 52-56
Kudesia, R.; Singer, T.; Caputo, T.A.; Holcomb, K.M.; Kligman, I.; Rosenwaks, Z.; Gupta, D. 2014: Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma American Journal of Obstetrics and Gynecology 210(3): 255.E1-4
Lindahl, B.; Willén, R. 1998: Flow cytometry as a prognostic method for the identification of adenomatous hyperplasia at risk of developing endometrial carcinoma Anticancer Research 18(6b): 4611-4612
Vishnevsky, A.S.; Bobrov JuF; Tsyrlina, E.V.; Dilman, V.M. 1993: Hyperinsulinemia as a factor modifying sensitivity of endometrial carcinoma to hormonal influences European Journal of Gynaecological Oncology 14(2): 127-130
Mangili, G.; De Marzi, P.; Viganò, R.; Rabaiotti, E.; Sassi, I.; Taccagni, G.L.; Garancini, P.; Frigerio, L. 2002: Identification of high risk patients with endometrial carcinoma. Prognostic assessment of endometrial cancer European Journal of Gynaecological Oncology 23(3): 216-220